---
figid: PMC9271773__fonc-12-829212-g005
figtitle: 'Targeting Adenylate Cyclase Family: New Concept of Targeted Cancer Therapy'
organisms:
- Mus musculus
- Cricetulus griseus
- Homo sapiens
- Gallus gallus
- Coxiella burnetii
organisms_ner:
- Mus musculus
- Homo sapiens
- Cricetulus griseus
- Gallus gallus
- Drosophila melanogaster
pmcid: PMC9271773
filename: fonc-12-829212-g005.jpg
figlink: /pmc/articles/PMC9271773/figure/f5/
number: F5
caption: ADCY family roles in cancer recurrence and prognosis. cAMP inhibits cancer
  formation by blocking extracellular signal-regulated kinase (ERK), inhibiting the
  antiapoptotic proteins Bcl2 and Bcl-XI, upregulating the cancer suppressor gene
  p53, inhibiting the oncogenes c-myc and erbB-2, and inhibiting the regulation of
  the angiogenic pathway by VEGF, TGF-β, and EGFR. However, many cancers exhibit lower
  AC levels and lower cAMP levels, promoting cancer formation as well as cancer cell
  proliferation, reducing apoptosis, and even promoting neovascularization, cancer
  cell migration, and invasion.
papertitle: 'Targeting Adenylate Cyclase Family: New Concept of Targeted Cancer Therapy.'
reftext: Rui Guo, et al. Front Oncol. 2022;12:829212.
year: '2022'
doi: 10.3389/fonc.2022.829212
journal_title: Frontiers in Oncology
journal_nlm_ta: Front Oncol
publisher_name: Frontiers Media S.A.
keywords: adenylate cyclase | cAMP signaling | molecular targeted therapy | chemoresistance
  | signaling pathway 4
automl_pathway: 0.948734
figid_alias: PMC9271773__F5
figtype: Figure
redirect_from: /figures/PMC9271773__F5
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9271773__fonc-12-829212-g005.html
  '@type': Dataset
  description: ADCY family roles in cancer recurrence and prognosis. cAMP inhibits
    cancer formation by blocking extracellular signal-regulated kinase (ERK), inhibiting
    the antiapoptotic proteins Bcl2 and Bcl-XI, upregulating the cancer suppressor
    gene p53, inhibiting the oncogenes c-myc and erbB-2, and inhibiting the regulation
    of the angiogenic pathway by VEGF, TGF-β, and EGFR. However, many cancers exhibit
    lower AC levels and lower cAMP levels, promoting cancer formation as well as cancer
    cell proliferation, reducing apoptosis, and even promoting neovascularization,
    cancer cell migration, and invasion.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Meg3
  - Niban2
  - Trp53
  - Myc
  - Nol3
  - Creb1
  - Bcl2
  - Bc1
  - Bc1-ps1
  - Igkv1-136
  - Sirt6
  - Vegfa
  - Egfr
  - MEG3
  - NIBAN2
  - TP53
  - TP63
  - TP73
  - MYC
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - BCL2
  - CHMP2A
  - SIRT6
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - EGFR
  - Tp53
  - p53
  - betaTub60D
  - hth
  - CrebB
  - CrebA
  - Debcl
  - bc2
  - BC1
  - CycE
  - cyc
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - Pvf1
  - Pvf2
  - Pvf3
  - Pvr
---
